Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolinerx Ltd ADR (NQ: BLRX )

1.300 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biolinerx Ltd ADR

< Previous 1 2 3 Next >
Week In Review: Henlius Signs $196 Million Deal For Two Oncology Bifunctional Sialidase Candidates
Shanghai Henlius Biotech acquired Greater China rights to two early-stage bifunctional sialidase candidates from Palleon Pharma, a Waltham, MA biopharma, in a deal with $196.5 million in development... 
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers Performance Shipping Inc. (NASDAQ: PSHG) rose 41.7% to $ 0.94 in pre-market trading. Performance Shipping shares dipped around 64% on Friday after the company announced the pricing of an... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 1Life Healthcare (NASDAQ:ONEM) shares moved upwards by 22.4% to $9.58 during Wednesday's after-market session. The market value of their outstanding shares is at $1.8 billion. The company's, Q1... 
Via Benzinga
Recap: BioLine Rx Q4 Earnings
BioLine Rx (NASDAQ:BLRX) reported its Q4 earnings results on Wednesday, March 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Earnings Preview: BioLine Rx
BioLine Rx (NASDAQ:BLRX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-16. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit. 
Via Benzinga
Recap: BioLine Rx Q1 Earnings
BioLine Rx (NASDAQ:BLRX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
BioLine Rx's Earnings Outlook
BioLine Rx (NASDAQ:BLRX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-16. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million. 
Via Benzinga
Banned diamonds
Pres. Biden plans to rap the oil reserve to lower gasoline prices by a million barrels per day for 180 mn barrels. 
Via Talk Markets
Monday Markets News
Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved. 
Via Talk Markets
Earnings Scheduled For March 16, 2022
Companies Reporting Before The Bell • Ideanomics (NASDAQ:IDEX) is likely to report quarterly loss at $0.05 per share on revenue of $33.20 million. • Tarena... 
Via Benzinga
A Receding tide
Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient. 
Via Talk Markets
A News Blizzard
Markets are still down despite very encouraging news in January when 467,00 new hires got jobs. 
Via Talk Markets
World Markets News for Wednesday
Gold and the Euro are up as the greenback loses traction. 
Via Talk Markets
World Markets News
Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish. 
Via Talk Markets
Chopped Stocks
The day's theme is sell tech and buy banks. 
Via Talk Markets
More Serious Matters
Wall Street fell on new worries about inflation and a drop in retail sales levels. 
Via Talk Markets
Happy New Year - Sunday Edition
Starting a new year - we look at tech, pharma and mining stocks and their goings-on. 
Via Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers OptiNose (NASDAQ:OPTN) shares mov... 
Via Benzinga
Dreaming Of A Red Christmas
The stock market is reacting with lots of selling to the weekend's news. 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Genfit (NASDAQ:GNFT) stock moved upwards by 38.55% to $4.6 during Friday's pre-market session. The market value of their outstanding shares is at $210.4... 
Via Benzinga
Uncertain Times
The UK inflation rate last month was 5.1%, not a good omen. 
Via Talk Markets
50 Biggest Movers From Friday
Gainers SigmaTron International, Inc. (NASDAQ: SGMA) jumped 84.7% to settle at $14.94 on Friday after the company reported Q2 EPS and sales results were higher year over year.... 
Via Benzinga
Inflation Surge
Today the market failed to brush off inflation fears as it had done later on Thursday as inflation is at a 4 decade high. 
Via Talk Markets
36 Stocks Moving In Friday's Mid-Day Session
Gainers American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) jumped 43.1% to $2.6909. American Virtual Cloud Technologies shares jumped over 82% on Thursday after the company... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 23.65% to $2.81 during Friday's regular session. As of 12:30 EST, BioLine Rx's stock is trading at a... 
Via Benzinga
Mid-Day Market Update: Oracle Gains Following Upbeat Q2 Results; Angion Biomedica Shares Drop
Midway through trading Friday, the Dow traded up 0.09% to 35,787.47 while the NASDAQ rose 0.11% to 15,534.76. The S&P also rose, gaining 0.38% to 4,685.15. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
recession in 2022?
China has cut its reserve requirement for lending by 50% giving a $188 bn boost to its market. 
Via Talk Markets
Topics Economy
Exposures Economy
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.